Subgroup Analyses Results of the Petacc8 Phase Iii Trial Comparing Adjuvant Folfox4 with or Without Cetuximab (Ctx) in Resected Stage Iii Colon Cancer (Cc).
AuthID
P-00P-8PV
P-00P-8PV
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service